Number of members
17572
Address
Wajun Building 2F, 2-22-2 Koishikawa, Bunkyo-ku, 112-0002 Tokyo, Japan

About

The Japan Diabetes Society (JDS) was established as a voluntary association in April 1958, with the aim of encouraging the progress and development of the study of diabetes and ultimately preventing suffering among people with diabetes in Japan.

At the time, Japan was still in a state of post-war recovery and diabetes was not given much attention. Nevertheless, having already foreseen that the number of people with diabetes would increase with the lifestyle changes that would certainly accompany the coming economic growth, early members of JDS were pressing forward earnestly with research into the origin and treatment of diabetes in Japan while studying research results from the West and working to translate their findings into clinical applications.

Following its establishment, JDS strove to disseminate an accurate understanding of diabetes by holding academic and scientific meetings, publishing its own journal, Tonyobyo (“Diabetes”) and issuing handouts such as Food Exchange Lists—Dietary Guidance for Persons with Diabetes, as well as other initiatives.

More than 60 years since its founding, JDS has continued to develop academic research programmes relating to the origins and treatment of diabetes and conduct activities aimed at improving the environment in which diabetes treatment takes place, in order to fulfill its social mission.

Main Focus

Action Plan, DREAMS:
(1) Diagnosis and care
(2) Research to cure
(3) Evidence for optimum care
(4) Alliance for diabetes
(5) Mentoring programme for prevention
(6) Stop diabetes

Publications & Newsletters

Diabetology International, the official journal of the Japan Diabetes Society, publishes original research articles about experimental research and clinical studies in diabetes and related areas. The journal also presents editorials, reviews, commentaries, reports of expert committees, and case reports on all aspects of diabetes. Diabetology International welcomes submissions from researchers, clinicians, and health professionals throughout the world who are interested in research, treatment, and care of people with diabetes.